| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.084 | 0.08 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.08 | 0.08 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.1 | 0.08 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.09 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |